108 related articles for article (PubMed ID: 15736455)
21. Overexpression of tissue inhibitor of metalloproteinases-3 in intestinal and cutaneous lesions of graft-versus-host disease.
Salmela MT; Karjalainen-Lindsberg ML; Jeskanen L; Saarialho-Kere U
Mod Pathol; 2003 Feb; 16(2):108-14. PubMed ID: 12591962
[TBL] [Abstract][Full Text] [Related]
22. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
[TBL] [Abstract][Full Text] [Related]
23. The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
Cross NA; Chandrasekharan S; Jokonya N; Fowles A; Hamdy FC; Buttle DJ; Eaton CL
Prostate; 2005 May; 63(3):269-75. PubMed ID: 15599946
[TBL] [Abstract][Full Text] [Related]
24. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
25. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
Dreger SA; Taylor PM; Allen SP; Yacoub MH
J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292
[TBL] [Abstract][Full Text] [Related]
26. Expression of MMP-9 decreases metastatic potential of Chondrosarcoma: an immunohistochemical study.
Malcherczyk D; Heyse TJ; El-Zayat BF; Kunzke V; Moll R; Fuchs-Winkelmann S; Paletta JRJ
BMC Musculoskelet Disord; 2018 Jan; 19(1):9. PubMed ID: 29316907
[TBL] [Abstract][Full Text] [Related]
27. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone.
el-Shabrawi Y; Eckhardt M; Berghold A; Faulborn J; Auboeck L; Mangge H; Ardjomand N
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():375-83. PubMed ID: 11027004
[TBL] [Abstract][Full Text] [Related]
28. Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direct effect on chondrocytes may not be pivotal.
Dai SM; Shan ZZ; Nishioka K; Yudoh K
Ann Rheum Dis; 2005 May; 64(5):735-42. PubMed ID: 15834055
[TBL] [Abstract][Full Text] [Related]
29. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).
Kashiwagi M; Tortorella M; Nagase H; Brew K
J Biol Chem; 2001 Apr; 276(16):12501-4. PubMed ID: 11278243
[TBL] [Abstract][Full Text] [Related]
30. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
[TBL] [Abstract][Full Text] [Related]
31. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
[TBL] [Abstract][Full Text] [Related]
32. Age-related changes in expression of tissue inhibitor of metalloproteinases-3 associated with transition from the notochordal nucleus pulposus to the fibrocartilaginous nucleus pulposus in rabbit intervertebral disc.
Tsuji T; Chiba K; Imabayashi H; Fujita Y; Hosogane N; Okada Y; Toyama Y
Spine (Phila Pa 1976); 2007 Apr; 32(8):849-56. PubMed ID: 17426628
[TBL] [Abstract][Full Text] [Related]
33. Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension.
Hamel MG; Ajmo JM; Leonardo CC; Zuo F; Sandy JD; Gottschall PE
Exp Neurol; 2008 Apr; 210(2):428-40. PubMed ID: 18178186
[TBL] [Abstract][Full Text] [Related]
34. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases during normal human pulmonary development.
Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
Histopathology; 2005 Oct; 47(4):410-9. PubMed ID: 16178896
[TBL] [Abstract][Full Text] [Related]
36. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
Pan CH; Wen CH; Lin CS
Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
[TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
[TBL] [Abstract][Full Text] [Related]
38. Expression of MMPs is dependent on the activity of mitogen-activated protein kinase in chondrosarcoma.
Yao M; Wang X; Zhao Y; Wang X; Gao F
Mol Med Rep; 2017 Feb; 15(2):915-921. PubMed ID: 28035378
[TBL] [Abstract][Full Text] [Related]
39. Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia.
Kumaki F; Matsui K; Kawai T; Ozeki Y; Yu ZX; Ferrans VJ; Travis WD
Am J Pathol; 2001 Dec; 159(6):2125-35. PubMed ID: 11733363
[TBL] [Abstract][Full Text] [Related]
40. Transcript levels of major MMPs and ADAMTS-4 in relation to the clinicopathological profile of patients with lumbar disc herniation.
Tsarouhas A; Soufla G; Katonis P; Pasku D; Vakis A; Spandidos DA
Eur Spine J; 2011 May; 20(5):781-90. PubMed ID: 20857147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
